E-submission
THE KOREAN LIVER CANCER ASSOCIATION
Articles
- Page Path
- HOME > J Liver Cancer > Volume 15(2); 2015 > Article
- Case Report A Case of Management for Early Recurrence after Hepatic Resection for the Treatment of Small Hepatocellular Carcinoma
- Kyung Woo Park1, Young Seok Kim1, Sang Gyune Kim1, Soung Won Jeong1, Jae Young Jang1, Hong Soo Kim1, Sae Hwan Lee1, Boo Sung Kim1, Jun Cheol Jeong2, Min Hee Lee3, Jae Myeong Lee3, Hee Kyung Kim4
-
Journal of Liver Cancer 2015;15(2):122-125
DOI: https://doi.org/10.17998/jlc.15.2.122
Published online: September 30, 2015
2Department of Surgery, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea
3Department of Radiology, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea
4Department of Pathology, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea
-
Corresponding author:
Young Seok Kim,
Email: liverkys@schmc.ac.kr
- 1,464 Views
- 10 Download
- 0 Crossref
- 0 Scopus
Abstract
For a small hepatocellular carcinoma (HCC), liver resection shows most favorable outcome in
case
which liver transplantation is not available, although it has also substantial recurrence
rate. Here, we report a case of recurred HCC with multiple intrahepatic metastasis at 5 months
after surgical resection for small HCC was done. A 55-year-old man with chronic HBV infection
received subsegmentectomy for HCC less than 2 cm. A follow-up computed tomography (CT)
at 5 months from operation revealed that there were multiple enhancing nodules in entire
remnant liver. Intra-arterial injections of adriamycin mixed lipiodol and gelfoam particles were
instituted through hepatic artery. We assume that poorly differentiated cellular feature would
be attributable to this kind of very early and aggressive recurrence of HCC. (J Liver Cancer
2015;15:122-125)
- Related articles
-
- Microwave ablation vs. liver resection for patients with hepatocellular carcinomas
- Exploring the role of liver resection as a first-line treatment option for multinodular BCLC-A hepatocellular carcinoma
- Disease modifiers and novel markers in hepatitis B virus-related hepatocellular carcinoma
- The role of lenvatinib in the era of immunotherapy of hepatocellular carcinoma
Follow JLC on Twitter